首页> 外文会议>Conference on laser and noncoherent light ocular effects: Epidemiology, prevention, and treatment >Untoward effects of high dose methylprednisolone therapy on blood-retinal barrier closure, retinal hole repair, and long-term scarring.
【24h】

Untoward effects of high dose methylprednisolone therapy on blood-retinal barrier closure, retinal hole repair, and long-term scarring.

机译:高剂量甲基己酮酮治疗对血尿动物屏障闭合,视网膜孔修复和长期瘢痕的影响。

获取原文

摘要

Thirty-seven New Zealand Red rabbits were either dosed with methylprednisolone sodium succinate (MP, n=18) about 20 min before laser irradiation, or they were left untreated (n=19). Dosing with MP was tapered at 30, 30, 20, 20, and 10 mg/kg/day for five consecutive days. Retinas were irradiated with a multi-line argon laser to produce retinal injuries (grid of 16 lesions/eye) near hemorrhaging levels (285 mW/10msec, 290 mum retinal spot size). A variety of funduscopic and histologic assessments were made for hemorrhagic and non-hemorrhagic lesions from 10 min to 6 mo after injury. Fluorescein angiography showed that non-hemorrhagic control lesions stopped leaking at 3d post injury, but MP-treated lesions leaked for 2-4 days longer. After MP treatment, funduscopic lesion areas were similar to controls during the first 24 h then became smaller by 1 mo. After 1 mo, MP-treated lesions increased in area while controls became reduced. Histologic analysis showed no effect on reduction of neutrophils (PMN) in MP-treated lesions over controls at 3 hr. At 24 hr, retinal PMN values in hemorrhagic lesions of the MP group were elevated (p<0.05) while monocyte/macrophage counts were reduced (p<0.05) compared to control. At 4d, MP impeded replacement of lost retinal tissue, and contributed to retinal hole development at 1 mo followed by extensive enhancement of chorio-retinal scarring at 6 mo. In severe laser-induced retinal trauma, the immunosuppressive effects of high dose MP therapy contributed to a variety of untoward wound healing outcomes, thereby suggesting caution in its use to treat similar injuries in humans.
机译:在激光照射之前,在激光照射之前,将三十七个新西兰红兔用甲基己酮酸钠(MP,n = 18)给予约20分钟,或者将它们未经处理(n = 19)。用MP给药在连续五天的30,30,20,20和10mg / kg /天中逐渐变细。用多线氩激激电照射了视网膜损伤(近6个病灶/眼网),靠近出血水平(285 mW / 10毫秒,290毫米视网膜点尺寸)。在损伤后10分钟至6μm,为出血和非出血病变进行各种眼底和组织学评估。荧光素血管造影表明,非出血控制病变在3D后损伤时停止泄漏,但MP处理的病变泄漏2-4天。在MP处理之后,在前24小时期间,眼底性病变区域与对照相似,然后变小1mo。在1Mo之后,在面积的情况下,在控制中增加了MP处理的病变,而控制变为减少。组织学分析表明,在3小时的对照中对MP处理的病变中的中性粒细胞(PMN)的降低没有影响。在24小时,在MP组的出血性病变中的视网膜PMN值升高(P <0.05),而单核细胞/巨噬细胞计数降低(P <0.05)与对照相比。在4D,MP阻碍替换失去的视网膜组织,并导致1Mo的视网膜孔发育,然后在6μm以6mo广泛增强拟核视网膜瘢痕。在严重激光诱导的视网膜创伤中,高剂量MP疗法的免疫抑制作用导致各种不乏伤口愈合结果,从而谨慎地谨慎治疗人类的类似伤害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号